Innovation in Women’s Health

At Pelvalon, we believe in finding simple solutions to difficult problems.
We aim to change the lives of women who suffer from loss of bowel control.
We are dedicated to helping women achieve confidence, control, and a better quality of life.

Founded in 2010, Pelvalon’s innovative new technology originated from Stanford University’s Biodesign program, a collaboration between the schools of Medicine and Engineering. The Biodesign program encourages the development of user-driven solutions to unmet medical needs, and we are proud to carry on the tradition of biomedical innovation. Pelvalon is privately held, and our investors include Norwich Ventures, a specialized venture capital firm focused on medical technology.

Learn more about our company achievements:


Our best-in-class leadership team is composed of a driven group of entrepreneurs, world-renowned physician advisors and clinical investigators, experts in commercial healthcare, and strong venture backing.


Miles Rosen CEO, Co-founder of Pelvalon

Miles is the Chief Executive Officer and a co-founder of Pelvalon. Miles has led the company from concept development to FDA clearance in under 5 years. Miles is a graduate of Stanford University with a B.S. in Biological Sciences and an M.S. in Bioengineering.

image description
Steve Herbowy Vice President, R&D and Co-founder of Pelvalon

Steve is the Vice President of Research and Development and a co-founder of Pelvalon. Prior to Pelvalon, Steve led a project team from concept through clinical trials at Nellix Endovascular. Steve holds an M.S. in Mechanical Engineering from Stanford University and a B.S. in Biological and Environment Engineering from Cornell University.

image description
Colby Holthouse Vice President, Marketing and Business Development

Colby joined Pelvalon in 2013. She brings over a decade of medical device commercialization experience to the company at Guidant, Medtronic, AccessClosure and several other start-ups. Colby has a B.A. in History from Stanford University and an M.B.A. from the Kellogg School of Management at Northwestern University.

image description
Darla Desmond Vice President, Health Economics

Darla joined Pelvalon in 2014. She brings 20 years of experience in health care including hospital administration, executive sales, and reimbursement. During her tenures at Kyphon, Medtronic and EndoGastric Solutions, Darla developed expertise in strategic health economics and reimbursement.

image description
Jon Ward Vice President, Sales

Jon joined Pelvalon in 2016 with more than 20 years of sales experience in the medical device industry, including specific category experience with incontinence and female pelvic health products. Most recently, he served as Southeast Area Sales Director, Urology and Pelvic Health, for Boston Scientific Corporation. Prior to Boston Scientific, Mr. Ward spent more than a decade in national and regional sales leadership positions at American Medical Systems. Jon has a B.S. in Biology at the University of North Carolina, Chapel Hill.

image description
Jerome Le Director, Manufacturing and Operations

Jerome joined Pelvalon in 2015. He has 20 years of extensive experience in medical device manufacturing and operations management. He has helped companies including Calibra Medical and Conor Medsystems develop manufacturing and operations from early startup to full commercial launch. Jerome has a B.A. in Business Management from Golden Gate University.

image description
Lynn Bougie Director, Quality and Regulatory

Lynn joined Pelvalon in 2014. She brings 10 years of experience in medical device quality assurance, regulatory affairs, and project management from concept to commercialization, including Boston Scientific, IOGYN, and TDC/Vention Medical. Lynn has a B.S. in Mechanical Engineering from Northeastern University.

image description
Cindy Domecus Consultant, Regulatory Affairs

Cindy Domecus, R.A.C. (US & EU) has worked in the medical device industry for over 25 years. Cindy was the Vice President of Regulatory Affairs and Clinical Research for Conceptus, Inc. and Kyphon, Inc. prior to starting her consulting practice in 2006. She was selected by FDA to serve as the Industry Representative to the OB/GYN Devices panel, where she served a 6-year term. She has led successful PMA, de novo, 510(k), IDE, and Pre-Sub efforts. She has a B.A. from University of the Pacific in Psychology and has attended executive education programs at Harvard School of Business and Kellogg School of Management.

image description

Board of Directors and Advisors

Rob Chess Eclipse System
Rob Chess
is Chairman of Nektar Therapeutics (NASDAQ:NKTR), a biopharmaceutical company, OPX Biotechnologies, a company in the renewable chemicals field, and Biota Technologies, a start-up developing industrial applications of the analysis of microbial communities. Rob has led Nektar as CEO through 1999 and as Chairman since then. Rob also served as the initial CEO for OPX and is a co-founder of Biota. Rob co-founded and was President of Penederm, a dermatology company that went public and was sold to Mylan Laboratories. He started his career in the technology field and held management positions at Intel and Metaphor Computer Systems (later acquired by IBM). Rob served on the White House Staff in the first Bush Administration as a White House Fellow and Associate Deputy Director of the White House Office of Economic and Domestic Policy. Rob received a B.S. in Engineering with honors from Caltech and an M.B.A. from Harvard.

Aaron Sandoski Eclipse System
Aaron Sandoski
is the Co-founder and Managing Director of Norwich Ventures, a seed and earlystage venture capital firm specializing in the medical device industry. Prior to founding Norwich Ventures, Aaron worked for DEKA R&D, the engineering think tank of Dean Kamen. Aaron has also worked in start-up operations where he helped launch a subsidiary of Express Scripts and helped launch a venture-backed payments company. Both companies were acquired in transactions totaling over $500 million. Aaron began his career as a consultant at McKinsey & Company, where he advised healthcare clients ranging from leading medical device companies to a rural hospital system. He is co-author of How the Wise Decide, a book for best practices in making tough decisions. Aaron earned an M.B.A. from Harvard Business School and graduated summa cum laude from Dartmouth College with a double A.B. in Chemistry and Economics.

Ross Longhini Eclipse System
Ross A. Longhini
is the Executive Partner and Co-founder of Voyageur Medical, a medical device innovation service provider. He has served as CTO, COO and CEO of American Medical Systems from 2003 to 2009. Ross has more than 28 years of experience in the field of medical device product development. From 1996 to 2002, he served in various management positions in SpineTech including Vice President, Research and Development, Clinical and Regulatory. Ross received a B.S. in Mechanical Engineering from Michigan Technological University.

Join us in changing the lives of patients

We strongly believe that the way things have been done is not necessarily the way things could be done. This attitude is ingrained in our culture and reflected in the medical need we are addressing, the type of technology we are developing, and all aspects of how we run our business.

We are always looking for people who share our passion for changing lives through thoughtful curiosity and efficient implementation of new solutions. If this fits your personality, please reach out to us.

Please visit our LinkedIn page to learn more about us and to see current job openings. For more information or to submit a resume, please contact us at